/
NEO
$16.06+$0.61 (+3.99%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$2.0B
128M shares
52-week range
$4.72 – $16.17
99% from low
Sector
SERVICES-TESTING LABORATORIES
Exchange
NASDAQ
CS
Change$-30.20
NeoGenomics, Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
www.neogenomics.com- Employees
- 2,500
- IPO / List date
- Jan 25, 1996
- HQ
- FORT MYERS, FL
Held by traders on TradeandTell
No one on the platform currently holds NEO.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 254,172 | $1.9M |
| Bridgewater Associatesas of 2026-03-31 | 91,190 | $676.6K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded NEO yet.
